Pitfalls in case-control studies of vaccine effectiveness.

1. Barricarte A, Castilla J, Gil-Setas A, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study. Clin Infect Dis 2007; 44:1436–41. 2. Grimes DA, Schutlz KF. Bias and causal associations in observational research. Lancet 2002; 359:248–52. 3. Bland JM, Altman DG. Matching. BMJ 1994; 309:1128. 4. Barricarte A, Gil-Setas A, Torroba A, et al. Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000–2005): impact of the conjugate vaccine [in Spanish]. Med Clin (Barc) 2007; 129:41–5. 5. Flannery B, Heffernan RT, Harrison LH, et al. Changes in invasive disease pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006; 144:1–9. 6. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784–92. 7. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998– 2003. MMWR Morb Mortal Wkly Rep 2005; 54:893–7. 8. Kellner JD, Church DL, MacDonald J, et al. Progress in prevention of pneumococcal disease. CMAJ 2005; 173:1149–51. 9. Roche P, Krause V, Cook H, et al. Invasive pneumococcal disease in Australia, 2005. Commun Dis Intell 2007; 31:86–100. 10. Aristegui J, Bernaola E, Pcheville I, et al. Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 2007; 26:303–10. Reprints or correspondence: Dr. Enrique Bernaola, Pediatrics Dept., Virgen del Camino Hospital, C/Irunlarrea 8, 31008– Pamplona, Spain ([email protected]). Clinical Infectious Diseases 2007; 45:1240–1 2007 by the Infectious Diseases Society of America. All rights reserved. 1058-4838/2007/4509-0020$15.00 DOI: 10.1086/523978